Revolution Medicines Inc <RVMD.O>: Wedbush raises target price to $192.1 from $181
RVMD•Related News
Palisade Bio Inc <PALI.O>: Oppenheimer initiates coverage with outperform rating; target price $8
PALI•
Norfolk Southern beats Q2 revenue estimates on volumes, fuel surcharge
NSC•
First Resource Bancorp Q2 net income rises
FRSB•
Norfolk Southern rides freight demand, fuel surcharges to quarterly profit beat
NSC•
Bridger Aerospace leases two Super Scooper aircraft to Avincis for Portugal wildfire operations through mid-October
BAER•